MicroPort Scientific (HKSE:00853) Total Liabilities : HK$19,754 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is MicroPort Scientific Total Liabilities?

MicroPort Scientific's Total Liabilities for the quarter that ended in Dec. 2023 was HK$19,754 Mil.

MicroPort Scientific's quarterly Total Liabilities increased from Dec. 2022 (HK$17,138.91 Mil) to Jun. 2023 (HK$17,951.53 Mil) and increased from Jun. 2023 (HK$17,951.53 Mil) to Dec. 2023 (HK$19,754.17 Mil).

MicroPort Scientific's annual Total Liabilities increased from Dec. 2021 (HK$16,869.53 Mil) to Dec. 2022 (HK$17,138.91 Mil) and increased from Dec. 2022 (HK$17,138.91 Mil) to Dec. 2023 (HK$19,754.17 Mil).

MicroPort Scientific Total Liabilities Historical Data

The historical data trend for MicroPort Scientific's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort Scientific Total Liabilities Chart

MicroPort Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

7,367.34

8,381.25

16,869.53

17,138.91

19,754.17

MicroPort Scientific Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															16,869.53	17,150.78	17,138.91	17,951.53	19,754.17

MicroPort Scientific Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

MicroPort Scientific's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9926.912	+	(7026.946	+	2720.083
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	80.23)
	=	19,754

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	30711.297	-	10957.126
	=	19,754

MicroPort Scientific's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9926.912	+	(7026.946	+	2720.083
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	80.23)
	=	19,754

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	30711.297	-	10957.126
	=	19,754

MicroPort Scientific Total Liabilities Related Terms

Thank you for viewing the detailed overview of MicroPort Scientific's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort Scientific (HKSE:00853) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort Scientific Corp (HKSE:00853) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

MCRPF:USA MSK:Germany

Address

1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201203

Website

https://www.microport.com

MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacture, R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacture, R&D of orthopedics devices. CRM business: sales, manufacture, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacture, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacture, R&D of neurovascular devices. Heart valve business: sales, manufacture, R&D of heart valve devices. Surgical robot business: sales, manufacture, R&D of surgical robot devices. Surgical devices business: sales, manufacture, R&D of surgical devices. The key revenue is from The PRC.

Executives

Shang Hai Zhang Jiang Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Maxwell Maxcare Science Foundation Limited	2201 Interest of corporation controlled by you
We'tron Capital Limited	2101 Beneficial owner
Hillhouse Investment Management, Ltd.	2102 Investment manager
Hfty I Holdings Pte. Ltd.	2101 Beneficial owner
Otsuka Holdings Co., Ltd.
Otsuka Medical Devices Co., Ltd.
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner

MicroPort Scientific (HKSE:00853) Headlines

No Headlines